Soleus Capital Management, L.P. Immunic, Inc. Transaction History
Soleus Capital Management, L.P.
- $1.18 Billion
- Q3 2024
A detailed history of Soleus Capital Management, L.P. transactions in Immunic, Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 7,293,007 shares of IMUX stock, worth $7.73 Million. This represents 1.02% of its overall portfolio holdings.
Number of Shares
7,293,007
Previous 7,293,007
-0.0%
Holding current value
$7.73 Million
Previous $8.1 Million
48.65%
% of portfolio
1.02%
Previous 0.82%
Shares
4 transactions
Others Institutions Holding IMUX
# of Institutions
70Shares Held
56.2MCall Options Held
100Put Options Held
350K-
Bvf Inc San Francisco, CA8.9MShares$9.44 Million0.47% of portfolio
-
Avidity Partners Management LP Dallas, TX8.27MShares$8.76 Million0.84% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.59MShares$5.93 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X05.1MShares$5.41 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$4.98 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $32.4M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...